A prospective, multi-Institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells

Hollis Viray Dr., Kevin Li, Thomas A. Long, Patricia Vasalos, Julia A. Bridge Dr., Lawrence J. Jennings Dr., Kevin C. Halling, Meera Hameed Dr., David L. Rimm Dr.

Research output: Research - peer-reviewArticle

  • 34 Citations

Abstract

Context.-The fraction of malignant cells in tumor tissue submitted for tests of genetic alterations is a critical variable in testing accuracy. That fraction is currently determined by pathologist visual estimation of the percentage of malignant cells. Inaccuracy could lead to a false-negative test result. Objective.-To describe a prospective, multi-institutional study to determine pathologist estimation accuracy. Design.-Ten320 magnification images of hematoxylineosin-stained colon tissue specimens were sent as an educational component of the College of American Pathologists KRAS-B 2011 Survey. Data from 194 labs were analyzed and compared to a criterion standard with comprehensive manual nuclear counts. Results.-Survey responses indicated low interlaboratory precision of pathologist estimation, but mean estimates were fairly accurate. A total of 5 of the 10 cases assessed showed more than 10% of respondents overestimating in a manner that could lead to false-negative test results. Conclusions.-The significance of estimation errors resulting in molecular testing failures with implications for patient care is unknown, but the current study suggests false-negative test results may occur.

LanguageEnglish (US)
Pages1545-1549
Number of pages5
JournalArchives of Pathology and Laboratory Medicine
Volume137
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Pathologists
Surveys and Questionnaires
Patient Care
Colon
Neoplasms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Viray Dr., H., Li, K., Long, T. A., Vasalos, P., Bridge Dr., J. A., Jennings Dr., L. J., ... Rimm Dr., D. L. (2013). A prospective, multi-Institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells. Archives of Pathology and Laboratory Medicine, 137(11), 1545-1549. DOI: 10.5858/arpa.2012-0561-CP

A prospective, multi-Institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells. / Viray Dr., Hollis; Li, Kevin; Long, Thomas A.; Vasalos, Patricia; Bridge Dr., Julia A.; Jennings Dr., Lawrence J.; Halling, Kevin C.; Hameed Dr., Meera; Rimm Dr., David L.

In: Archives of Pathology and Laboratory Medicine, Vol. 137, No. 11, 11.2013, p. 1545-1549.

Research output: Research - peer-reviewArticle

Viray Dr., H, Li, K, Long, TA, Vasalos, P, Bridge Dr., JA, Jennings Dr., LJ, Halling, KC, Hameed Dr., M & Rimm Dr., DL 2013, 'A prospective, multi-Institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells' Archives of Pathology and Laboratory Medicine, vol 137, no. 11, pp. 1545-1549. DOI: 10.5858/arpa.2012-0561-CP
Viray Dr., Hollis ; Li, Kevin ; Long, Thomas A. ; Vasalos, Patricia ; Bridge Dr., Julia A. ; Jennings Dr., Lawrence J. ; Halling, Kevin C. ; Hameed Dr., Meera ; Rimm Dr., David L./ A prospective, multi-Institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells. In: Archives of Pathology and Laboratory Medicine. 2013 ; Vol. 137, No. 11. pp. 1545-1549
@article{26e99c0813d94edca0c1a36d4850585a,
title = "A prospective, multi-Institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells",
abstract = "Context.-The fraction of malignant cells in tumor tissue submitted for tests of genetic alterations is a critical variable in testing accuracy. That fraction is currently determined by pathologist visual estimation of the percentage of malignant cells. Inaccuracy could lead to a false-negative test result. Objective.-To describe a prospective, multi-institutional study to determine pathologist estimation accuracy. Design.-Ten320 magnification images of hematoxylineosin-stained colon tissue specimens were sent as an educational component of the College of American Pathologists KRAS-B 2011 Survey. Data from 194 labs were analyzed and compared to a criterion standard with comprehensive manual nuclear counts. Results.-Survey responses indicated low interlaboratory precision of pathologist estimation, but mean estimates were fairly accurate. A total of 5 of the 10 cases assessed showed more than 10% of respondents overestimating in a manner that could lead to false-negative test results. Conclusions.-The significance of estimation errors resulting in molecular testing failures with implications for patient care is unknown, but the current study suggests false-negative test results may occur.",
author = "{Viray Dr.}, Hollis and Kevin Li and Long, {Thomas A.} and Patricia Vasalos and {Bridge Dr.}, {Julia A.} and {Jennings Dr.}, {Lawrence J.} and Halling, {Kevin C.} and {Hameed Dr.}, Meera and {Rimm Dr.}, {David L.}",
year = "2013",
month = "11",
doi = "10.5858/arpa.2012-0561-CP",
volume = "137",
pages = "1545--1549",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "11",

}

TY - JOUR

T1 - A prospective, multi-Institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells

AU - Viray Dr.,Hollis

AU - Li,Kevin

AU - Long,Thomas A.

AU - Vasalos,Patricia

AU - Bridge Dr.,Julia A.

AU - Jennings Dr.,Lawrence J.

AU - Halling,Kevin C.

AU - Hameed Dr.,Meera

AU - Rimm Dr.,David L.

PY - 2013/11

Y1 - 2013/11

N2 - Context.-The fraction of malignant cells in tumor tissue submitted for tests of genetic alterations is a critical variable in testing accuracy. That fraction is currently determined by pathologist visual estimation of the percentage of malignant cells. Inaccuracy could lead to a false-negative test result. Objective.-To describe a prospective, multi-institutional study to determine pathologist estimation accuracy. Design.-Ten320 magnification images of hematoxylineosin-stained colon tissue specimens were sent as an educational component of the College of American Pathologists KRAS-B 2011 Survey. Data from 194 labs were analyzed and compared to a criterion standard with comprehensive manual nuclear counts. Results.-Survey responses indicated low interlaboratory precision of pathologist estimation, but mean estimates were fairly accurate. A total of 5 of the 10 cases assessed showed more than 10% of respondents overestimating in a manner that could lead to false-negative test results. Conclusions.-The significance of estimation errors resulting in molecular testing failures with implications for patient care is unknown, but the current study suggests false-negative test results may occur.

AB - Context.-The fraction of malignant cells in tumor tissue submitted for tests of genetic alterations is a critical variable in testing accuracy. That fraction is currently determined by pathologist visual estimation of the percentage of malignant cells. Inaccuracy could lead to a false-negative test result. Objective.-To describe a prospective, multi-institutional study to determine pathologist estimation accuracy. Design.-Ten320 magnification images of hematoxylineosin-stained colon tissue specimens were sent as an educational component of the College of American Pathologists KRAS-B 2011 Survey. Data from 194 labs were analyzed and compared to a criterion standard with comprehensive manual nuclear counts. Results.-Survey responses indicated low interlaboratory precision of pathologist estimation, but mean estimates were fairly accurate. A total of 5 of the 10 cases assessed showed more than 10% of respondents overestimating in a manner that could lead to false-negative test results. Conclusions.-The significance of estimation errors resulting in molecular testing failures with implications for patient care is unknown, but the current study suggests false-negative test results may occur.

UR - http://www.scopus.com/inward/record.url?scp=84887830506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887830506&partnerID=8YFLogxK

U2 - 10.5858/arpa.2012-0561-CP

DO - 10.5858/arpa.2012-0561-CP

M3 - Article

VL - 137

SP - 1545

EP - 1549

JO - Archives of Pathology and Laboratory Medicine

T2 - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 11

ER -